The people it speaks toFieldwork March 2022
24% of US adults
say digestive health is the most important aspect of their overall health, per a 2022 IFIC survey on gut health and probiotics.
International Food Information Council, 2022Daily Probiotic
Daily Probiotic.
Backed by human trials
Saccharomyces boulardii CNCM I-745 is the lead active here, studied most for gut barrier integrity. 7 human studies on Saccharomyces boulardii CNCM I-745 back this formula, each one cited. Who it fits: for everyone, adults.
Full label disclosure
1Active ingredient7Human studies500 mgSaccharomyces boulardii CNCM I-745
Verified by IngredientMDHow we read this product
- 01We read the label.
The panel on the left is the one we evaluated, line by line.
- 02Every active, separately.
All 1 actives checked against the clinical evidence: dose, form, and what the research actually shows.
- 03Then the formula as a whole.
Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Backed by human trials".
- 04Earned, not bought.
The verdict is public and identical whether or not a brand pays. A formula that does not clear the bar gets nothing.
Read by the engine against 2.1 million data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.
The receipts
7
Human studies
500 mg
Saccharomyces boulardii CNCM I-745
Read the evidenceSaccharomyces boulardii CNCM I-745, the evidence →
Inside the formula
In context
The gap this formula speaks to.
Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.
The people it speaks toFieldwork January 22 to 26, 2026
52% of US adults
believe common digestive symptoms such as bloating and abdominal pain are just a normal part of life, per a 2026 Harris Poll conducted for Oshi Health.
The Harris Poll for Oshi Health, 2026The people it speaks toFieldwork 2017 to 2018
58% of the recommended fiber intake
was reached on average by US consumers, who ate 8.1 grams of fiber per 1,000 calories in 2017 to 2018 versus the 14 grams recommended, per USDA Economic Research Service analysis of federal food consumption survey data.
USDA Economic Research Service, 2023The people it speaks toFieldwork March 28 to 29, 2023
40% of US adults
aged 18 and over report they experience bloating at least a few times a month, with 5% saying they experience it daily, per a 2023 Ipsos poll conducted for MDVIP.
Ipsos, 2023The people it speaks toFieldwork March 28 to 29, 2023
34% of US adults
aged 18 and over report they experience abdominal discomfort or pain at least a few times per month, with women about twice as likely as men to report it several times weekly, per a 2023 Ipsos poll conducted for MDVIP.
Ipsos, 2023The people it speaks toFieldwork March 28 to 29, 2023
28% of US adults
aged 18 and over say that digestive issues impact the quality of their life, a share that rises to about a third among those aged 18 to 44, per a 2023 Ipsos poll conducted for MDVIP.
Ipsos, 20239 more
32% of US adults
say they actively try to consume probiotics, and among them 60% try to do so at least once a day, per a 2022 IFIC survey on gut health.
International Food Information Council, 202259 to 66 days
was the median time it took adults to make a new daily health habit automatic across the studies a 2024 review pooled, with individuals ranging from 4 to 335 days.
Systematic review and meta-analysis, 202461% to 74%
About 61 to 74 percent of adults refilling a long-term medicine on their own stopped within a year, versus 33 to 44 percent on one set pickup day.
Cohort study, 2015Randomised trial, 2017
Taking a yeast probiotic alongside an antibiotic course was linked to smaller shifts in gut bacteria than the antibiotic alone, in a randomized study.
Gut MicrobesKabbani et al., 2017 (Gut Microbes)PMID 27973989
Cohort study, 2026
A real-world registry analysis reports effectiveness and tolerability figures for the yeast used as an adjunct. Being observational, it describes association within routine practice and not causation.
HelicobacterNyssen et al., 2026 (Helicobacter)PMID 41923280
Randomised trial, 2023
In adults with sudden onset loose stools, the CNCM I-745 strain shortened the time taken for stool form and bowel frequency to return to normal compared with usual care.
BMC GastroenterologySalazar-Parra et al., 2023 (BMC Gastroenterology)PMID 37400812
Randomised trial, 2020
In students supplemented ahead of examinations, the yeast shifted stress-related blood markers, while examination performance itself did not differ detectably from placebo.
NutrientsKarbownik et al., 2020 (Nutrients)PMID 32438624
Randomised trial, 2016
In preterm infants, the CNCM I-745 strain improved feeding tolerance and shortened time to full feeds. Growth measures did not differ detectably between groups.
Jornal de PediatriaXu et al., 2016 (Jornal de Pediatria)PMID 26946967
Meta-analysis, 2024
Pooling trials of a four-drug antibacterial regimen with and without the yeast, the authors report differences in reported digestive complaints during therapy.
Frontiers in MedicineChen et al., 2024 (Frontiers in Medicine)PMID 38695028
Population figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Every one of these is a fact the engine could ground.
Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.
- Studied in people7 human studies on Saccharomyces boulardii CNCM I-745 back this formula, each one cited.
- A mechanism that is settledHow Saccharomyces boulardii CNCM I-745 works is settled pharmacology.
- Why this formatIt is a capsule, so the amount per serving is fixed and travels without measuring.
- The exact form, describedThe form on the label is Freeze-dried powder in capsules. The record says what that form is and what it suits.
- Full label disclosureEvery ingredient on this label carries its own declared amount.
- Where it comes from and how it is madeSaccharomyces boulardii CNCM I-745 is made by fermentation.
- Positions this formula already qualifies forThis formula already qualifies for positions beyond the one it is sold into, on the evidence it carries.
- A position nobody is holding yetSome of those positions are ones almost nobody is selling to yet.
How each ingredient usually behaves over time.
One ingredient, from its own page.
- Saccharomyces boulardii CNCM I-745Three days
To reach steady levels in the gut, with most reports of steadier regularity inside the first week of daily use.
How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.
Capsule
It is a capsule, so the amount per serving is fixed and travels without measuring.
Best forMost standard doses, and anywhere a short, clean label is the point.
Questions shoppers ask
- Is Daily Probiotic independently verified?
- Yes. IngredientMD reviewed this formula independently and verified it in Oct 2026. The verdict is earned, not bought: brands can't edit or purchase it.
- What's in Daily Probiotic?
- Daily Probiotic is built on Saccharomyces boulardii CNCM I-745. Each ingredient links to its own evidence page on IngredientMD.
- Who is IngredientMD?
- IngredientMD is an independent supplement-science platform. We analyze ingredients and formulas against clinical research, and we verify products only when they clear our bar. Labs run the tests. We review the results.
Sell a formula this good?
Put an earned verification on your own product page.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.
Independent review by IngredientMD, not commissioned by FlorastorWork at Florastor? This verification is yours to claim →